ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
+13.97%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$1.53B
AUM Growth
+$1.53B
(+20%)
Cap. Flow
+$192M
Cap. Flow
% of AUM
12.51%
Top 10 Holdings %
Top 10 Hldgs %
63.05%
Holding
50
New
9
Increased
18
Reduced
7
Closed
4
Top Buys
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$52.7M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$28.2M |
| 3 |
Bristol-Myers Squibb
BMY
|
$28M |
| 4 |
TG Therapeutics
TGTX
|
$27M |
| 5 |
AstraZeneca
AZN
|
$26M |
Top Sells
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
$89.4M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
$25.2M |
| 3 |
Pacira BioSciences
PCRX
|
$21.1M |
| 4 |
MDCO
Medicines Co
MDCO
|
$11.6M |
| 5 |
DBVT
DBV Technologies
DBVT
|
$8.22M |
Sector Composition
| 1 | Healthcare | 77.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $260M | 16.83% | 16,064,461 +1,325,000 | +9% | +$21.4M |
|
|
2
BioMarin Pharmaceuticals
BMRN
$11.2B
| $106M | 6.88% | 1,189,524 +591,552 | +99% | +$52.7M |
|
3
Amicus Therapeutics
FOLD
$2.34B
| $105M | 6.77% | 7,263,122 +826,000 | +13% | +$11.9M |
|
|
MRTX
4
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $80.3M | 5.2% | 4,398,101 +687,500 | +19% | +$12.5M |
|
|
CLVS
5
DELISTED
Clovis Oncology, Inc.
CLVS
| $75M | 4.86% | 1,102,884 +317,184 | +40% | +$21.6M |
|
|
GBT
6
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $72.5M | 4.7% | 1,841,896 +717,596 | +64% | +$28.2M |
|
|
ARRY
7
DELISTED
Array Biopharma Inc
ARRY
| $70M | 4.54% | 5,468,029 +115,000 | +2% | +$1.47M |
|
8
Ascendis Pharma
ASND
$11.8B
| $67.3M | 4.36% | 1,681,024 +44,900 | +3% | +$1.8M |
|
|
AVXS
9
DELISTED
AveXis, Inc. Common Stock
AVXS
| $66M | 4.28% | 596,217 +159,515 | +37% | +$17.7M |
|
|
HZNP
10
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $64.8M | 4.2% | 4,436,183 +920,083 | +26% | +$13.4M |
|
11
argenx
ARGX
$43.6B
| $50.8M | 3.29% | 804,875 +375,275 | +87% | +$23.7M |
|
|
ZGNX
12
DELISTED
Zogenix, Inc.
ZGNX
| $50.6M | 3.28% | 1,263,313 +236,945 | +23% | +$9.49M |
|
13
Assembly Biosciences
ASMB
$190M
| $48.4M | 3.13% | 1,068,534 +161,372 | +18% | +$7.3M |
|
|
DERM
14
DELISTED
Dermira, Inc.
DERM
| $42.3M | 2.74% | 1,520,000 | – | – |
|
15
Iovance Biotherapeutics
IOVA
$807M
| $42M | 2.72% | 5,253,450 +1,052,107 | +25% | +$8.42M |
|
|
16
Pacira BioSciences
PCRX
$1.2B
| $38.7M | 2.51% | 848,572 -462,888 | -35% | -$21.1M |
|
|
MDCO
17
DELISTED
Medicines Co
MDCO
| $35.4M | 2.3% | 1,296,560 -423,833 | -25% | -$11.6M |
|
|
18
Bristol-Myers Squibb
BMY
$96B
| $28M | 1.81% | +456,223 | New | +$28M |
|
|
19
TG Therapeutics
TGTX
$4.65B
| $27M | 1.75% | +3,294,463 | New | +$27M |
|
|
20
AstraZeneca
AZN
$248B
| $26M | 1.69% | +750,300 | New | +$26M |
|
21
Vanda Pharmaceuticals
VNDA
$279M
| $21.4M | 1.39% | 1,408,946 +420,676 | +43% | +$6.39M |
|
|
TLGT
22
DELISTED
Teligent, Inc
TLGT
| $18.3M | 1.19% | 5,049,431 +471,201 | +10% | +$1.71M |
|
|
MYOK
23
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $16.8M | 1.09% | 398,207 | – | – |
|
24
Catalyst Pharmaceutical
CPRX
$2.52B
| $15.2M | 0.99% | 3,892,343 -743,402 | -16% | -$2.91M |
|
25
Indaptus Therapeutics
INDP
$7.19M
| $11.3M | 0.73% | 2,195,705 | – | – |
|